GB1314792A - Alkali metal and ammonium salts of thymolphthalein monophosphate and the production thereof - Google Patents
Alkali metal and ammonium salts of thymolphthalein monophosphate and the production thereofInfo
- Publication number
- GB1314792A GB1314792A GB1373471A GB1373471A GB1314792A GB 1314792 A GB1314792 A GB 1314792A GB 1373471 A GB1373471 A GB 1373471A GB 1373471 A GB1373471 A GB 1373471A GB 1314792 A GB1314792 A GB 1314792A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkali metal
- alkaline phosphatase
- production
- ammonium salts
- thymolphthalein monophosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- JWBPMLSZYOGYFD-UHFFFAOYSA-N [4-[1-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-3-oxo-2-benzofuran-1-yl]-5-methyl-2-propan-2-ylphenyl] dihydrogen phosphate Chemical class C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(OP(O)(O)=O)=C(C(C)C)C=2)C)=C1C JWBPMLSZYOGYFD-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 title abstract 2
- 150000001340 alkali metals Chemical class 0.000 title abstract 2
- 150000003863 ammonium salts Chemical class 0.000 title abstract 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 abstract 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 abstract 4
- 239000013060 biological fluid Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
1314792 Determination of alkaline phosphatase WORTHINGTON BIOCHEMICAL CORP 7 May 1971 [5 June 1970] 13734/71 Heading B1X [Also in Division C2] The alkaline phosphatase content of blood serum and other biological fluids is determined using a solution containing 3 mg per ml of an alkali metal or ammonium salt of thymolphthalein monophosphate. In the presence of alkaline phosphatase thymolphalein is released, and the increase in optical density gives a measure of the quantity of alkaline phosphatase.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4398370A | 1970-06-05 | 1970-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1314792A true GB1314792A (en) | 1973-04-26 |
Family
ID=21929916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1373471A Expired GB1314792A (en) | 1970-06-05 | 1971-05-07 | Alkali metal and ammonium salts of thymolphthalein monophosphate and the production thereof |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA924729A (en) |
| DE (1) | DE2127655C3 (en) |
| ES (1) | ES390893A1 (en) |
| FR (1) | FR2095945A5 (en) |
| GB (1) | GB1314792A (en) |
-
1971
- 1971-04-23 CA CA111187A patent/CA924729A/en not_active Expired
- 1971-05-05 ES ES390893A patent/ES390893A1/en not_active Expired
- 1971-05-07 GB GB1373471A patent/GB1314792A/en not_active Expired
- 1971-06-03 DE DE19712127655 patent/DE2127655C3/en not_active Expired
- 1971-06-04 FR FR7120359A patent/FR2095945A5/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2127655B2 (en) | 1973-09-06 |
| CA924729A (en) | 1973-04-17 |
| DE2127655C3 (en) | 1974-04-04 |
| FR2095945A5 (en) | 1972-02-11 |
| DE2127655A1 (en) | 1971-12-09 |
| ES390893A1 (en) | 1973-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1359402A (en) | Process and reagent for the specific determination of creatinine | |
| GB1463173A (en) | Corrosion inhibitor | |
| ES433929A1 (en) | Reagent and method for determining leukocytes and hemoglobin in the blood | |
| SU513645A3 (en) | Reagent for the determination of glucose | |
| GB1358828A (en) | Process for detecting the presence of human carcinoembryonic antigen material or component a or b thereof in blood | |
| ES431736A1 (en) | Preparation of a diagnostic agent for measuring the coagulability of blood | |
| GB1213014A (en) | Testing blood for the presence of haemoglobins | |
| GB1322464A (en) | Triglyceride assay system | |
| GB1211721A (en) | Laboratory reagent for assay of acid or alkaline phosphatase | |
| GB1371209A (en) | Prostatic acid phosphatase determination | |
| DE3474041D1 (en) | Enzymatic urea assay | |
| GB1407247A (en) | Flowthrough cuvette | |
| GB1314792A (en) | Alkali metal and ammonium salts of thymolphthalein monophosphate and the production thereof | |
| GB1274089A (en) | Blood platelet stabilising reagent | |
| GB1278036A (en) | Diagnostic device | |
| GB1486523A (en) | S-acyl compounds and their use in determining lipase activity | |
| GB1372812A (en) | Cerebrospinal fluid control standard | |
| GB1164255A (en) | Improvements in or relating to Diagnostic Package. | |
| ES2036234T3 (en) | A METHOD TO DETERMINE THE ACTIVITY OF THE ISOENZYME DL-1 OF BIOLOGICAL FLUIDS. | |
| GB1516898A (en) | Cephalexin containing antibiotic composition | |
| GB1263202A (en) | Alkaline phosphatase test | |
| FR2214887A1 (en) | Creatine kinase determination - using N-acetyl cystein as activator in reaction of creatine phosphate and ADP to form creatine and ATP | |
| GB1452648A (en) | Cholera toxoid | |
| GB1449146A (en) | Prostaglandins and the preparation thereof | |
| GB1308281A (en) | 5-azaspiro-2.4-heptanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |